Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
PCMT1 encodes a member of the type II class of protein carboxyl methyltransferase enzymes. Additionally we are shipping Protein-L-Isoaspartate (D-Aspartate) O-Methyltransferase Proteins (14) and Protein-L-Isoaspartate (D-Aspartate) O-Methyltransferase Kits (10) and many more products for this protein.
Showing 10 out of 53 products:
Human Monoclonal PCMT1 Primary Antibody for WB - ABIN393496
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010
Show all 5 references for ABIN393496
Human Monoclonal PCMT1 Primary Antibody for WB - ABIN393808
Martins-de-Souza, Maccarrone, Wobrock, Zerr, Gormanns, Reckow, Falkai, Schmitt, Turck: Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia. in Journal of psychiatric research 2010
Show all 5 references for ABIN393808
Chicken Polyclonal PCMT1 Primary Antibody for WB - ABIN2773925
Kosugi, Furuchi, Katane, Sekine, Shirasawa, Homma: Suppression of protein l-isoaspartyl (d-aspartyl) methyltransferase results in hyperactivation of EGF-stimulated MEK-ERK signaling in cultured mammalian cells. in Biochemical and biophysical research communications 2008
Human Polyclonal PCMT1 Primary Antibody for ICC, IF - ABIN4344090
Forsström, Axnäs, Stengele, Bühler, Albert, Richmond, Hu, Nilsson, Hudson, Rockberg, Uhlen: Proteome-wide epitope mapping of antibodies using ultra-dense peptide arrays. in Molecular & cellular proteomics : MCP 2014
Strong PIMT expression was a predictive marker of poor prognosis for surgically resected lung adenocarcinoma.
The data of this study indicated that DA-associated PIMT downregulation is an important event contributing to neuronal cell death
ERK2 (show MAPK1 Antibodies)-mediated phosphorylation of transcriptional coactivator binding protein PIMT/NCoA6IP (show TGS1 Antibodies) at Ser298 augments hepatic gluconeogenesis.
Overexpression of PCMT1 attentuates Mst1 (show MST1 Antibodies) kinase activation and its apoptotic effects in response to hypoxia-induced injury in cardiomyocytes.
Data indicate that human PROTEIN ISOASPARTYL METHYLTRANSFERASE (PIMT) can initiate isoAsp conversion to Asp (show ASIP Antibodies), and is able to restore Arabidopsis PRH75 (show DDX46 Antibodies)'s complex biochemical activity provided isoAsp formation has not led to conformational alterations.
Data show six differentially expressed proteins were identified as HSP70 (show HSP70 Antibodies), PPIA (show PPIA Antibodies) and alpha-Enolase (show ENO1 Antibodies) (up-regulated) S100-A9, PIMT and beta-5 tubulin (show TUBB Antibodies) (down-regulated), most of which had been shown to play a potential role in the pathogenesis of atherosclerosis.
The results implied that maternal polymorphisms in PCMT1 might be a potential genetic risk factor for isolated anencephaly in the Chinese population of Lvliang.
Study provides new insight into the molecular mechanisms by which PIMT suppresses the p53 (show TP53 Antibodies) activity through carboxyl methylation, and suggests a therapeutic target for cancers.
PIMT may act as a co-activator in ERalpha (show ESR1 Antibodies)-mediated transcription of TFF1 (show TFF1 Antibodies) through its recruitment to the promoter via interacting with ERalpha (show ESR1 Antibodies).
Control of PCMT1 expression by microRNA 15a/16-1 may thus represent a late checkpoint in apoptosis regulation
Loss of normal CKB (show CHKB Antibodies) structure and function contributes to the mechanisms by which isoaspartate accumulation leads to central nervous system dysfunction in the PIMT-Knockout mouse.
PIMT levels may significantly influence the course of age-related central nervous system dysfunction.
PIMT knockout mice have perturbations in glutamate (show GRIN1 Antibodies) metabolism in the brain and die prematurely of epileptic seizures.
synuclein is not a major target of PIMT in vivo
Altered levels of S-adenosylmethionine and S-adenosylhomocysteine in the brains of PCMT1 knockout mice
Recombinant adeno (show ADORA2A Antibodies)-PIMT improved the symptoms of PIMT-deficient mice in vivo, but only partially repaired IsoAsp in damaged proteins.
An accumulation of isoaspartyl residues in cells of mice lacking the isoaspartyl repair enzyme PCMT alters the effector function of T lymphocytes leading to autoantibody production.
Pcmt1-/- mice have altered regulation of the insulin (show INS Antibodies) pathway, possibly as a compensatory response to altered glucose uptake or metabolism or as an adaptive response to a general accumulation of isoaspartyl protein damage in the brain and other tissues.
Protein L-isoaspartyl methyltransferase (PIMT) catalyzes in vivo racemization of Asp (show C3 Antibodies)-25 in mammalian histone H2B, suggesting that PIMT functions in the repair, rather than the metabolic turnover, of isoaspartyl proteins in vivo.
This gene encodes a member of the type II class of protein carboxyl methyltransferase enzymes. The encoded enzyme plays a role in protein repair by recognizing and converting D-aspartyl and L-isoaspartyl residues resulting from spontaneous deamidation back to the normal L-aspartyl form. The encoded protein may play a protective role in the pathogenesis of Alzheimer's disease, and single nucleotide polymorphisms in this gene have been associated with spina bifida and premature ovarian failure. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
L-isoaspartyl protein carboxyl methyltransferase
, protein L-isoaspartyl/D-aspartyl methyltransferase
, protein-L-isoaspartate(D-aspartate) O-methyltransferase
, protein-beta-aspartate methyltransferase
, protein carboxyl-o-methyltransferase
, protein carboxyl methyltransferase